What does BioLight Life Sciences Ltd. do?

BioLight Life Sciences Ltd. (BOLT.TA) operates in the Medical - Specialties industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is BOLT.TA's market cap?

BioLight Life Sciences Ltd. (BOLT.TA) has a market capitalization of approximately $2.47 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does BOLT.TA pay a dividend?

No — BioLight Life Sciences Ltd. (BOLT.TA) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Is BOLT.TA profitable?

BioLight Life Sciences Ltd. (BOLT.TA) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

BOLT.TA

BioLight Life Sciences Ltd.

TLV·Medical, Specialties · Healthcare

ILA 273.50ILA 1.60+0.59%

Market capILA 2.47B·Aug 26 7:37 AM UTC

Price Chart

ILA 273.50+ILA 1.60 (+0.59%)today

−75.80%CAGR −24.71%

Select date range

FromTo

Dec 27, 2005Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

BOLT.TA does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateApr 8

Last Report DateApr 8

Reported vs Estimate−ILA 1.71

Earnings Surprise—

FinancialsFinancials Tab

Revenue₪0.00

Net Income−₪11.73M

Net Margin—

Operating Cash Flow−₪10.85M

Capital Expenditures₪5.00K

Free Cash Flow−₪10.86M

Return on Equity−34.1%

Return on Invested Capital−18.5%

Net Cash₪22.88M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for BOLT.TA and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how BOLT.TA's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for BOLT.TA and 80,000+ other tickers.

About BioLight Life Sciences Ltd.

BioLight Life Sciences Ltd. is an ophthalmic firm dedicated to discovering, developing, and bringing to market innovative products and pipeline candidates designed to tackle various eye-related ailments. Its portfolio and development pipeline include DiagnosTear's TeaRx, a diagnostic platform analyzing tear fluid components to identify frontal eye diseases, and Peripherex, offering solutions for both at-home and clinical diagnosis and monitoring of peripheral vision loss, crucial for conditions like glaucoma. For glaucoma, BioLight features ViSci (an Eye D technology utilizing a…

CEO: Yaacov Michlin
Sector: Healthcare
Industry: Medical - Specialties
Exchange: TLV
Employees: 4
Website: bio-light.co.il

Peers

Merchavia Holdings and Investments Ltd.

Cap

ILA 3.3B

EMTC-M.TA

Elbit Medical Technologies Ltd

Cap

ILA 2.0B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About BOLT.TA

What does BioLight Life Sciences Ltd. do?: BioLight Life Sciences Ltd. (BOLT.TA) operates in the Medical - Specialties industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is BOLT.TA's market cap?: BioLight Life Sciences Ltd. (BOLT.TA) has a market capitalization of approximately $2.47 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does BOLT.TA pay a dividend?: No — BioLight Life Sciences Ltd. (BOLT.TA) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is BOLT.TA profitable?: BioLight Life Sciences Ltd. (BOLT.TA) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.